Yelin Lapidot Holdings Management Ltd. Arvinas, Inc. Transaction History
Yelin Lapidot Holdings Management Ltd.
- $567 Billion
- Q2 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 49,503 shares of ARVN stock, worth $1.27 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
49,503
Previous 49,503
-0.0%
Holding current value
$1.27 Million
Previous $2.04 Billion
35.51%
% of portfolio
0.23%
Previous 0.42%
Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
68.7MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$172 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$171 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$160 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$102 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$76.5 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.36B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...